Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Thomas

Showing results (351-360 of 441) with videos related to

Pageof 45
Sort By:
JAMA|July 24, 2012
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panelMelanie A Thompson, Judith A Aberg, Jennifer F Hoy, et al.
Frontiers in Aging Neuroscience|April 3, 2026
Ultra-fast MRI for brain-age prediction in a real-world cognitive disorders clinicRafael Navarro-González, Rodrigo de Luis-García, Santiago Aja-Fernández, et al.
Journal of Immunological Methods|February 11, 2023
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responsesNora Pisanic, Annukka A R Antar, Kate L Kruczynski, et al.
Open Forum Infectious Diseases|July 18, 2024
Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional StudyTalia A Loeb, Mihili P Gunaratne, Syed Iqbal, et al.
Journal of Hepatology|July 19, 2015
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearanceThomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapyMoses R Kamya, Harriet Mayanja-Kizza, Andrew Kambugu, et al.
Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Journal of Viral Hepatitis|November 15, 2024
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income CountriesRenae Furl, Kimberly K Scarsi, Harlan Sayles, et al.
The Journal of Infectious Diseases|September 13, 2024
Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom ResolutionNora Pisanic, Annukka A R Antar, Marissa K Hetrich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
Pageof 45

Showing results (351-360 of 441) with videos related to

Sort By:
Pageof 45
JAMA|July 24, 2012
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panelMelanie A Thompson, Judith A Aberg, Jennifer F Hoy, et al.
Frontiers in Aging Neuroscience|April 3, 2026
Ultra-fast MRI for brain-age prediction in a real-world cognitive disorders clinicRafael Navarro-González, Rodrigo de Luis-García, Santiago Aja-Fernández, et al.
Journal of Immunological Methods|February 11, 2023
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responsesNora Pisanic, Annukka A R Antar, Kate L Kruczynski, et al.
Open Forum Infectious Diseases|July 18, 2024
Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional StudyTalia A Loeb, Mihili P Gunaratne, Syed Iqbal, et al.
Journal of Hepatology|July 19, 2015
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearanceThomas R O'Brien, Ruth M Pfeiffer, Ashley Paquin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2007
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapyMoses R Kamya, Harriet Mayanja-Kizza, Andrew Kambugu, et al.
Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Journal of Viral Hepatitis|November 15, 2024
Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income CountriesRenae Furl, Kimberly K Scarsi, Harlan Sayles, et al.
The Journal of Infectious Diseases|September 13, 2024
Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom ResolutionNora Pisanic, Annukka A R Antar, Marissa K Hetrich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
Pageof 45